1. Home
  2. SOCAU vs DRRX Comparison

SOCAU vs DRRX Comparison

Compare SOCAU & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOCAU
  • DRRX
  • Stock Information
  • Founded
  • SOCAU N/A
  • DRRX 1998
  • Country
  • SOCAU United States
  • DRRX United States
  • Employees
  • SOCAU N/A
  • DRRX N/A
  • Industry
  • SOCAU Blank Checks
  • DRRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SOCAU Finance
  • DRRX Health Care
  • Exchange
  • SOCAU Nasdaq
  • DRRX Nasdaq
  • Market Cap
  • SOCAU N/A
  • DRRX 59.3M
  • IPO Year
  • SOCAU 2025
  • DRRX 2000
  • Fundamental
  • Price
  • SOCAU $10.07
  • DRRX $1.92
  • Analyst Decision
  • SOCAU
  • DRRX Hold
  • Analyst Count
  • SOCAU 0
  • DRRX 1
  • Target Price
  • SOCAU N/A
  • DRRX N/A
  • AVG Volume (30 Days)
  • SOCAU N/A
  • DRRX 487.4K
  • Earning Date
  • SOCAU N/A
  • DRRX 08-12-2025
  • Dividend Yield
  • SOCAU N/A
  • DRRX N/A
  • EPS Growth
  • SOCAU N/A
  • DRRX N/A
  • EPS
  • SOCAU N/A
  • DRRX N/A
  • Revenue
  • SOCAU N/A
  • DRRX $1,657,000.00
  • Revenue This Year
  • SOCAU N/A
  • DRRX N/A
  • Revenue Next Year
  • SOCAU N/A
  • DRRX $673.00
  • P/E Ratio
  • SOCAU N/A
  • DRRX N/A
  • Revenue Growth
  • SOCAU N/A
  • DRRX N/A
  • 52 Week Low
  • SOCAU N/A
  • DRRX $0.48
  • 52 Week High
  • SOCAU N/A
  • DRRX $2.64
  • Technical
  • Relative Strength Index (RSI)
  • SOCAU N/A
  • DRRX 78.08
  • Support Level
  • SOCAU N/A
  • DRRX $1.86
  • Resistance Level
  • SOCAU N/A
  • DRRX $1.96
  • Average True Range (ATR)
  • SOCAU 0.00
  • DRRX 0.04
  • MACD
  • SOCAU 0.00
  • DRRX -0.04
  • Stochastic Oscillator
  • SOCAU 0.00
  • DRRX 60.00

About SOCAU Solarius Capital Acquisition Corp. Units

Solarius Capital Acquisition Corp is a blank check company.

About DRRX DURECT Corporation

Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories, which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from Europe.

Share on Social Networks: